[1]
Kaya, Özge et al. 2023. Long-term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?. Dermatology Practical & Conceptual. 13, 3 (Jul. 2023), e2023145. DOI:https://doi.org/10.5826/dpc.1303a145.